publish rjee rjfi
givaudan headquart vernier switzerland
lead manufactur flavour fragranc
global market share sale
fragranc flavour
account sale
cosmet ingredi key growth driver
acquisit solianc induchem spicetek
contribut flavour
 price previou day close unless
footnot price-to-earnings multipl base averag share price
respect year
feedback roadshow citral impact push back
citral impact less expect host roadshow givaudan
june boston/new york key takeaway better-
than-expect mitig citral suppli issu concomit raw materi
inflat like result margin pressur push
confirm import naturex acquisit strateg fit
confid integr synergi next two year estim
sale integr busi solut key
address chang dynam fast-moving-consum good
industri thu rais fragranc margin vs
previous reduc citral impact vs previous
midterm cost synergi naturex acquisit
growth prospect along gb save key catalyst maintain
market perform givaudan fx comp less favour
dcf point estim fair valu vs
previous upsid potenti yesterday close price
citral impact push organ growth trend unchang givaudan
abl mitig citral shortag inventori
suppli basf impact thu like seen
less magnitud help compens basf forecast
impact vs gradual recoveri like
delay impact reduc rate also like show
well symris continu least affect due in-hous
capabl expect organ growth
naturex tick box group strategi
posit rapid integr naturex import valu
driver givaudan expect naturex add sale
total integr strengthen natur
flavour portfolio signific sourc capabl cosmet activ
offer importantli access adjac ingredi colour plant-
base antioxid natur stabil botan extract
well solut necessari develop integr busi solut
naturex also clearli expos smaller local player reduc
givaudan exposur larger food manufactur naturex ebitda
margin dilut givaudan go forward vs
previous although integr cost synergi
gb network expect deliv save rais
naturex margin naturex irr also histor
lower vs givaudan due lower margin
high work capit requir portfolio natur inventori
day sale naturex vs givaudan averag
pleas read domest foreign disclosure/risk inform begin page analyst certif page
raymond jame euro equiti rjee authoris regul autorit de contrl prudentiel et de rsolut autorit de march financi cib
raymond jame intern limit rjfi authoris regul uk conduct author frn collect refer raymond
integr solut key address structur chang industri view industri
chang rapidli smaller player strong emphasi market sell on-lin savvi grow much
faster global player slower react new consum trend tradit distribut channel
shelf-spac although still import continu challeng internet-bas order particularli emerg
market new player clearli agil innov focus natur product mainli food
applic innocentdrink uk bem brazil lifeaid beverag compani jc brazi bite top creameri
exampl also perfum cosmet segment eo seed beauti matchco beauti counter expect
smaller player clearli grow faster global compani increasingli contribut organ
growth next decad bode well givaudan gb initi tailor solut cater clientel
faster order reduc overal deliveri time togeth dedic salesforc organ
chang forecast sale forecast move mainli due fx weaker euro
ebitda howev move mainli due fragranc effect mitig
estim impact citral suppli shortag
valuat forecast chang dcf-base estim air valu point assum wacc
pension liabil total net debt revenu compound-annual-growth-rate see page
compani data rje estim ebitda consensu report adjust special
chang forecast
sale estim move fragranc sale forecast move
driven fx vs previous weaker euro vs chf
flavour sale forecast move fx vs previous ebitda
howev move fragranc
mitig impact citral suppli shortag estim vs previous
see net debt previou estim higher
sale estim move
lower base ebitda estim also move lower
growth vs consensu fx organ growth vs organ growth vs pre post incom debt end net debt includ purchas naturex organ growth vs organ growth vs comp strong fine fragranc fragranc organ growth vs growth matur market emerg givaudan
exhibit givaudan chang forecast chf million
thomson rje estim research ebitda consensu report adjust special
chf pre pre consolid organ report report report jv report tax incom incom dilut ep dilut givaudan
incom growth growth pre margin pre pre margin incom incom number dilut ep adjust post trade interest flow top increase/ net europ research
balanc term intang term term term term term equiti liabil givaudan
valuat fair valu
exhibit givaudan dcf assumpt fair valu estim ep reconcili impli price-to-earnings fair valu chf million
compani data rje estim thomson friday june
givaudanvaluevalu per sharesalesebitdaebitaev/salesev/ebitdaev/ebitanumb share elimin per shareep per dataep price-to-earnings share datacalcul net asset year financi multipl fair vs averag vs vs averag vs valuework gross tangibl asset gross valu acement gross gross irr gross cf pre year europ research
